The global market for HIV Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for HIV Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Therapeutics.

The HIV Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HIV Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the HIV Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of HIV Therapeutics Market Report

Report Metric	Details
Report Name	HIV Therapeutics Market
CAGR	5%
Segment by Type	Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Entry and Fusion Inhibitors Protease Inhibitors (PIs) Integrase Inhibitors Coreceptor Antagonists
Segment by Application	Hospitals Clinics Labs
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Boehringer Ingelheim International GmbH, Merck & Co., ViiV Healthcare, AbbVie, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, Gilead Sciences, Johnson & Johnson, Cipla Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the HIV Therapeutics Market report?

Ans: The main players in the HIV Therapeutics Market are Boehringer Ingelheim International GmbH, Merck & Co., ViiV Healthcare, AbbVie, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, Gilead Sciences, Johnson & Johnson, Cipla Limited

What are the Application segmentation covered in the HIV Therapeutics Market report?

Ans: The Applications covered in the HIV Therapeutics Market report are Hospitals, Clinics, Labs

What are the Type segmentation covered in the HIV Therapeutics Market report?

Ans: The Types covered in the HIV Therapeutics Market report are Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Entry and Fusion Inhibitors, Protease Inhibitors (PIs), Integrase Inhibitors, Coreceptor Antagonists

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global HIV Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)

1.2.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

1.2.4 Entry and Fusion Inhibitors

1.2.5 Protease Inhibitors (PIs)

1.2.6 Integrase Inhibitors

1.2.7 Coreceptor Antagonists

1.3 Market by Application

1.3.1 Global HIV Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Labs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global HIV Therapeutics Market Perspective (2020-2031)

2.2 Global HIV Therapeutics Growth Trends by Region

2.2.1 Global HIV Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 HIV Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 HIV Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 HIV Therapeutics Market Dynamics

2.3.1 HIV Therapeutics Industry Trends

2.3.2 HIV Therapeutics Market Drivers

2.3.3 HIV Therapeutics Market Challenges

2.3.4 HIV Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top HIV Therapeutics Players by Revenue

3.1.1 Global Top HIV Therapeutics Players by Revenue (2020-2025)

3.1.2 Global HIV Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global HIV Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by HIV Therapeutics Revenue

3.4 Global HIV Therapeutics Market Concentration Ratio

3.4.1 Global HIV Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by HIV Therapeutics Revenue in 2024

3.5 Global Key Players of HIV Therapeutics Head office and Area Served

3.6 Global Key Players of HIV Therapeutics, Product and Application

3.7 Global Key Players of HIV Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 HIV Therapeutics Breakdown Data by Type

4.1 Global HIV Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global HIV Therapeutics Forecasted Market Size by Type (2026-2031)

5 HIV Therapeutics Breakdown Data by Application

5.1 Global HIV Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global HIV Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America HIV Therapeutics Market Size (2020-2031)

6.2 North America HIV Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America HIV Therapeutics Market Size by Country (2020-2025)

6.4 North America HIV Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe HIV Therapeutics Market Size (2020-2031)

7.2 Europe HIV Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe HIV Therapeutics Market Size by Country (2020-2025)

7.4 Europe HIV Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific HIV Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific HIV Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific HIV Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific HIV Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America HIV Therapeutics Market Size (2020-2031)

9.2 Latin America HIV Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America HIV Therapeutics Market Size by Country (2020-2025)

9.4 Latin America HIV Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa HIV Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa HIV Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa HIV Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa HIV Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Boehringer Ingelheim International GmbH

11.1.1 Boehringer Ingelheim International GmbH Company Details

11.1.2 Boehringer Ingelheim International GmbH Business Overview

11.1.3 Boehringer Ingelheim International GmbH HIV Therapeutics Introduction

11.1.4 Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2020-2025)

11.1.5 Boehringer Ingelheim International GmbH Recent Development

11.2 Merck & Co.

11.2.1 Merck & Co. Company Details

11.2.2 Merck & Co. Business Overview

11.2.3 Merck & Co. HIV Therapeutics Introduction

11.2.4 Merck & Co. Revenue in HIV Therapeutics Business (2020-2025)

11.2.5 Merck & Co. Recent Development

11.3 ViiV Healthcare

11.3.1 ViiV Healthcare Company Details

11.3.2 ViiV Healthcare Business Overview

11.3.3 ViiV Healthcare HIV Therapeutics Introduction

11.3.4 ViiV Healthcare Revenue in HIV Therapeutics Business (2020-2025)

11.3.5 ViiV Healthcare Recent Development

11.4 AbbVie

11.4.1 AbbVie Company Details

11.4.2 AbbVie Business Overview

11.4.3 AbbVie HIV Therapeutics Introduction

11.4.4 AbbVie Revenue in HIV Therapeutics Business (2020-2025)

11.4.5 AbbVie Recent Development

11.5 F. Hoffmann-La Roche Ltd.

11.5.1 F. Hoffmann-La Roche Ltd. Company Details

11.5.2 F. Hoffmann-La Roche Ltd. Business Overview

11.5.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Introduction

11.5.4 F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2020-2025)

11.5.5 F. Hoffmann-La Roche Ltd. Recent Development

11.6 Teva Pharmaceutical Industries Ltd.

11.6.1 Teva Pharmaceutical Industries Ltd. Company Details

11.6.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.6.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Introduction

11.6.4 Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2020-2025)

11.6.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.7 Bristol-Myers Squibb

11.7.1 Bristol-Myers Squibb Company Details

11.7.2 Bristol-Myers Squibb Business Overview

11.7.3 Bristol-Myers Squibb HIV Therapeutics Introduction

11.7.4 Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2020-2025)

11.7.5 Bristol-Myers Squibb Recent Development

11.8 Gilead Sciences

11.8.1 Gilead Sciences Company Details

11.8.2 Gilead Sciences Business Overview

11.8.3 Gilead Sciences HIV Therapeutics Introduction

11.8.4 Gilead Sciences Revenue in HIV Therapeutics Business (2020-2025)

11.8.5 Gilead Sciences Recent Development

11.9 Johnson & Johnson

11.9.1 Johnson & Johnson Company Details

11.9.2 Johnson & Johnson Business Overview

11.9.3 Johnson & Johnson HIV Therapeutics Introduction

11.9.4 Johnson & Johnson Revenue in HIV Therapeutics Business (2020-2025)

11.9.5 Johnson & Johnson Recent Development

11.10 Cipla Limited

11.10.1 Cipla Limited Company Details

11.10.2 Cipla Limited Business Overview

11.10.3 Cipla Limited HIV Therapeutics Introduction

11.10.4 Cipla Limited Revenue in HIV Therapeutics Business (2020-2025)

11.10.5 Cipla Limited Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim International GmbH

Merck

ViiV Healthcare

AbbVie

F Hoffmann La Roche Ltd

Teva Pharmaceutical Industries Ltd

List of Tables

Table 1. Global HIV Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)

Table 3. Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Table 4. Key Players of Entry and Fusion Inhibitors

Table 5. Key Players of Protease Inhibitors (PIs)

Table 6. Key Players of Integrase Inhibitors

Table 7. Key Players of Coreceptor Antagonists

Table 8. Global HIV Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global HIV Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global HIV Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global HIV Therapeutics Market Share by Region (2020-2025)

Table 12. Global HIV Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global HIV Therapeutics Market Share by Region (2026-2031)

Table 14. HIV Therapeutics Market Trends

Table 15. HIV Therapeutics Market Drivers

Table 16. HIV Therapeutics Market Challenges

Table 17. HIV Therapeutics Market Restraints

Table 18. Global HIV Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global HIV Therapeutics Market Share by Players (2020-2025)

Table 20. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapeutics as of 2024)

Table 21. Ranking of Global Top HIV Therapeutics Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by HIV Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of HIV Therapeutics, Headquarters and Area Served

Table 24. Global Key Players of HIV Therapeutics, Product and Application

Table 25. Global Key Players of HIV Therapeutics, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global HIV Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global HIV Therapeutics Revenue Market Share by Type (2020-2025)

Table 29. Global HIV Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global HIV Therapeutics Revenue Market Share by Type (2026-2031)

Table 31. Global HIV Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global HIV Therapeutics Revenue Market Share by Application (2020-2025)

Table 33. Global HIV Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global HIV Therapeutics Revenue Market Share by Application (2026-2031)

Table 35. North America HIV Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America HIV Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America HIV Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe HIV Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe HIV Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe HIV Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific HIV Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific HIV Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific HIV Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America HIV Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America HIV Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America HIV Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa HIV Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa HIV Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa HIV Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 50. Boehringer Ingelheim International GmbH Company Details

Table 51. Boehringer Ingelheim International GmbH Business Overview

Table 52. Boehringer Ingelheim International GmbH HIV Therapeutics Product

Table 53. Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2020-2025) & (US$ Million)

Table 54. Boehringer Ingelheim International GmbH Recent Development

Table 55. Merck & Co. Company Details

Table 56. Merck & Co. Business Overview

Table 57. Merck & Co. HIV Therapeutics Product

Table 58. Merck & Co. Revenue in HIV Therapeutics Business (2020-2025) & (US$ Million)

Table 59. Merck & Co. Recent Development

Table 60. ViiV Healthcare Company Details

Table 61. ViiV Healthcare Business Overview

Table 62. ViiV Healthcare HIV Therapeutics Product

Table 63. ViiV Healthcare Revenue in HIV Therapeutics Business (2020-2025) & (US$ Million)

Table 64. ViiV Healthcare Recent Development

Table 65. AbbVie Company Details

Table 66. AbbVie Business Overview

Table 67. AbbVie HIV Therapeutics Product

Table 68. AbbVie Revenue in HIV Therapeutics Business (2020-2025) & (US$ Million)

Table 69. AbbVie Recent Development

Table 70. F. Hoffmann-La Roche Ltd. Company Details

Table 71. F. Hoffmann-La Roche Ltd. Business Overview

Table 72. F. Hoffmann-La Roche Ltd. HIV Therapeutics Product

Table 73. F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2020-2025) & (US$ Million)

Table 74. F. Hoffmann-La Roche Ltd. Recent Development

Table 75. Teva Pharmaceutical Industries Ltd. Company Details

Table 76. Teva Pharmaceutical Industries Ltd. Business Overview

Table 77. Teva Pharmaceutical Industries Ltd. HIV Therapeutics Product

Table 78. Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2020-2025) & (US$ Million)

Table 79. Teva Pharmaceutical Industries Ltd. Recent Development

Table 80. Bristol-Myers Squibb Company Details

Table 81. Bristol-Myers Squibb Business Overview

Table 82. Bristol-Myers Squibb HIV Therapeutics Product

Table 83. Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2020-2025) & (US$ Million)

Table 84. Bristol-Myers Squibb Recent Development

Table 85. Gilead Sciences Company Details

Table 86. Gilead Sciences Business Overview

Table 87. Gilead Sciences HIV Therapeutics Product

Table 88. Gilead Sciences Revenue in HIV Therapeutics Business (2020-2025) & (US$ Million)

Table 89. Gilead Sciences Recent Development

Table 90. Johnson & Johnson Company Details

Table 91. Johnson & Johnson Business Overview

Table 92. Johnson & Johnson HIV Therapeutics Product

Table 93. Johnson & Johnson Revenue in HIV Therapeutics Business (2020-2025) & (US$ Million)

Table 94. Johnson & Johnson Recent Development

Table 95. Cipla Limited Company Details

Table 96. Cipla Limited Business Overview

Table 97. Cipla Limited HIV Therapeutics Product

Table 98. Cipla Limited Revenue in HIV Therapeutics Business (2020-2025) & (US$ Million)

Table 99. Cipla Limited Recent Development

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Authors List of This Report

List of Figures

Figure 1. HIV Therapeutics Picture

Figure 2. Global HIV Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global HIV Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Features

Figure 5. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features

Figure 6. Entry and Fusion Inhibitors Features

Figure 7. Protease Inhibitors (PIs) Features

Figure 8. Integrase Inhibitors Features

Figure 9. Coreceptor Antagonists Features

Figure 10. Global HIV Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global HIV Therapeutics Market Share by Application: 2024 VS 2031

Figure 12. Hospitals Case Studies

Figure 13. Clinics Case Studies

Figure 14. Labs Case Studies

Figure 15. HIV Therapeutics Report Years Considered

Figure 16. Global HIV Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global HIV Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global HIV Therapeutics Market Share by Region: 2024 VS 2031

Figure 19. Global HIV Therapeutics Market Share by Players in 2024

Figure 20. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapeutics as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by HIV Therapeutics Revenue in 2024

Figure 22. North America HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America HIV Therapeutics Market Share by Country (2020-2031)

Figure 24. United States HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe HIV Therapeutics Market Share by Country (2020-2031)

Figure 28. Germany HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific HIV Therapeutics Market Share by Region (2020-2031)

Figure 36. China HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America HIV Therapeutics Market Share by Country (2020-2031)

Figure 44. Mexico HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa HIV Therapeutics Market Share by Country (2020-2031)

Figure 48. Turkey HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE HIV Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Boehringer Ingelheim International GmbH Revenue Growth Rate in HIV Therapeutics Business (2020-2025)

Figure 52. Merck & Co. Revenue Growth Rate in HIV Therapeutics Business (2020-2025)

Figure 53. ViiV Healthcare Revenue Growth Rate in HIV Therapeutics Business (2020-2025)

Figure 54. AbbVie Revenue Growth Rate in HIV Therapeutics Business (2020-2025)

Figure 55. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in HIV Therapeutics Business (2020-2025)

Figure 56. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in HIV Therapeutics Business (2020-2025)

Figure 57. Bristol-Myers Squibb Revenue Growth Rate in HIV Therapeutics Business (2020-2025)

Figure 58. Gilead Sciences Revenue Growth Rate in HIV Therapeutics Business (2020-2025)

Figure 59. Johnson & Johnson Revenue Growth Rate in HIV Therapeutics Business (2020-2025)

Figure 60. Cipla Limited Revenue Growth Rate in HIV Therapeutics Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions